Pegzilarginase in combination with agonist anti-OX40 therapy enhances T cell priming and effector function leading to improved tumor regression and survival

user-5f8cf7e04c775ec6fa691c92(2018)

引用 0|浏览4
暂无评分
关键词
Tumor-infiltrating lymphocytes,T cell,Immunotherapy,Agonist,Cancer,Effector,Cancer research,Priming (psychology),Medicine,Tumor regression
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要